default author photo

Nicole D. Fleming

University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine

SCHOLARLY PAPERS

3

DOWNLOADS

219

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Perioperative Outcomes in Gynecologic Pelvic Exenteration Before and after Implementation of an Enhanced Recovery after Surgery Program

Number of pages: 29 Posted: 04 Jul 2024
University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 126 (572,948)

Abstract:

Loading...

Enhanced Recovery After Surgery, pelvic exenteration, gynecologic surgery, surgical outcomes

2.

Phase II Trial of Pembrolizumab in Combination with Chemotherapy for Frontline Treatment of Advanced Epithelial Ovarian Cancer

Number of pages: 44 Posted: 28 Mar 2024
University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, Texas Oncology, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, Texas Oncology, University of Texas at Houston - Department of Genomic Medicine and University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine
Downloads 49 (1,074,648)

Abstract:

Loading...

pembrolizumab, combination chemotherapy, ovarian cancer, immunotherapy, tumor immune microenvironment, translational, clinical trial, feasibility

3.

Hormonal Therapy in Low-Grade Endometrial Stromal Sarcoma; What is the Current Standard of Care?

Number of pages: 25 Posted: 30 May 2024
affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Texas at Houston - Department of Gynecologic Oncology and Reproductive Medicine, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center and affiliation not provided to SSRN
Downloads 44 (1,133,231)

Abstract:

Loading...

Endometrial Stromal Sarcoma, low-grade ESS, uterine sarcoma, hormonal therapy, Megace, Letrozole